188 related articles for article (PubMed ID: 29802361)
1. The use of Ki-67 labeling index to grade pulmonary well-differentiated neuroendocrine neoplasms: current best evidence.
Marchevsky AM; Hendifar A; Walts AE
Mod Pathol; 2018 Oct; 31(10):1523-1531. PubMed ID: 29802361
[TBL] [Abstract][Full Text] [Related]
2. Limited additive value of the Ki-67 proliferative index on patient survival in World Health Organization-classified pulmonary carcinoids.
Swarts DR; Rudelius M; Claessen SM; Cleutjens JP; Seidl S; Volante M; Ramaekers FC; Speel EJ
Histopathology; 2017 Feb; 70(3):412-422. PubMed ID: 27701763
[TBL] [Abstract][Full Text] [Related]
3. The Role of Histologic Grading and Ki-67 Index in Predicting Outcomes in Pulmonary Carcinoid Tumors.
Dermawan JKT; Farver CF
Am J Surg Pathol; 2020 Feb; 44(2):224-231. PubMed ID: 31490236
[TBL] [Abstract][Full Text] [Related]
4. Evaluation of diagnostic and prognostic significance of Ki-67 index in pulmonary carcinoid tumours.
Clay V; Papaxoinis G; Sanderson B; Valle JW; Howell M; Lamarca A; Krysiak P; Bishop P; Nonaka D; Mansoor W
Clin Transl Oncol; 2017 May; 19(5):579-586. PubMed ID: 27848218
[TBL] [Abstract][Full Text] [Related]
5. Are goblet cell carcinoids a group of heterogeneous tumors?
Macak J; Nemejcova K; Dvorackova J
Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub; 2017 Sep; 161(3):281-285. PubMed ID: 28659644
[TBL] [Abstract][Full Text] [Related]
6. Molecular markers help characterize neuroendocrine lung tumors.
Rusch VW; Klimstra DS; Venkatraman ES
Ann Thorac Surg; 1996 Sep; 62(3):798-809; discussion 809-10. PubMed ID: 8784011
[TBL] [Abstract][Full Text] [Related]
7. Limited role of Ki-67 proliferative index in predicting overall short-term survival in patients with typical and atypical pulmonary carcinoid tumors.
Walts AE; Ines D; Marchevsky AM
Mod Pathol; 2012 Sep; 25(9):1258-64. PubMed ID: 22575865
[TBL] [Abstract][Full Text] [Related]
8. Divergent cyclin B1 expression and Rb/p16/cyclin D1 pathway aberrations among pulmonary neuroendocrine tumors.
Igarashi T; Jiang SX; Kameya T; Asamura H; Sato Y; Nagai K; Okayasu I
Mod Pathol; 2004 Oct; 17(10):1259-67. PubMed ID: 15154011
[TBL] [Abstract][Full Text] [Related]
9. Neuroendocrine Tumor Heterogeneity Adds Uncertainty to the World Health Organization 2010 Classification: Real-World Data from the Spanish Tumor Registry (R-GETNE).
Nuñez-Valdovinos B; Carmona-Bayonas A; Jimenez-Fonseca P; Capdevila J; Castaño-Pascual Á; Benavent M; Pi Barrio JJ; Teule A; Alonso V; Custodio A; Marazuela M; Segura Á; Beguiristain A; Llanos M; Martinez Del Prado MP; Diaz-Perez JA; Castellano D; Sevilla I; Lopez C; Alonso T; Garcia-Carbonero R
Oncologist; 2018 Apr; 23(4):422-432. PubMed ID: 29330208
[TBL] [Abstract][Full Text] [Related]
10. Diagnosis and management of typical and atypical lung carcinoids.
Pusceddu S; Lo Russo G; Macerelli M; Proto C; Vitali M; Signorelli D; Ganzinelli M; Scanagatta P; Duranti L; Trama A; Buzzoni R; Pelosi G; Pastorino U; de Braud F; Garassino MC
Crit Rev Oncol Hematol; 2016 Apr; 100():167-76. PubMed ID: 26917456
[TBL] [Abstract][Full Text] [Related]
11. Prognostic Immunohistochemistry for Ki-67 and OTP on Small Biopsies of Pulmonary Carcinoid Tumors: Ki-67 Index Predicts Progression-free Survival and Atypical Histology.
Naso JR; Jenkins SM; Roden AC; Yi ES; Lo YC; Bois MC; Maleszewski JJ; Aubry MC; Boland JM
Am J Surg Pathol; 2024 Jun; 48(6):742-750. PubMed ID: 38584496
[TBL] [Abstract][Full Text] [Related]
12. [Grading of neuroendocrine tumors].
Saeger W; Schnabel PA; Komminoth P
Pathologe; 2016 Jul; 37(4):304-13. PubMed ID: 27379621
[TBL] [Abstract][Full Text] [Related]
13. Orthopedia homeobox is preferentially expressed in typical carcinoids of the lung.
Hanley KZ; Dureau ZJ; Cohen C; Shin DM; Owonikoko TK; Sica GL
Cancer Cytopathol; 2018 Apr; 126(4):236-242. PubMed ID: 29316326
[TBL] [Abstract][Full Text] [Related]
14. Distinctive pathological and clinical features of lung carcinoids with high proliferation index.
Marchiò C; Gatti G; Massa F; Bertero L; Filosso P; Pelosi G; Cassoni P; Volante M; Papotti M
Virchows Arch; 2017 Dec; 471(6):713-720. PubMed ID: 28631159
[TBL] [Abstract][Full Text] [Related]
15. Interobserver variability for the WHO classification of pulmonary carcinoids.
Swarts DR; van Suylen RJ; den Bakker MA; van Oosterhout MF; Thunnissen FB; Volante M; Dingemans AM; Scheltinga MR; Bootsma GP; Pouwels HM; van den Borne BE; Ramaekers FC; Speel EJ
Am J Surg Pathol; 2014 Oct; 38(10):1429-36. PubMed ID: 25046341
[TBL] [Abstract][Full Text] [Related]
16. [Pulmonary neuroendocrine tumors. The spectrum of histologic subtypes and current concept on diagnosis and treatment].
Langfort R; Rudziński P; Burakowska B
Pneumonol Alergol Pol; 2010; 78(1):33-46. PubMed ID: 20162517
[TBL] [Abstract][Full Text] [Related]
17. [Pulmonary neuroendocrine tumors and preneoplasic lesions].
Rouquette Lassalle I
Ann Pathol; 2016 Jan; 36(1):34-43. PubMed ID: 26776366
[TBL] [Abstract][Full Text] [Related]
18. Stage IV lung carcinoids: spectrum and evolution of proliferation rate, focusing on variants with elevated proliferation indices.
Rekhtman N; Desmeules P; Litvak AM; Pietanza MC; Santos-Zabala ML; Ni A; Montecalvo J; Chang JC; Beras A; Preeshagul IR; Sabari JK; Rudin CM; Ladanyi M; Klimstra DS; Travis WD; Lai WC
Mod Pathol; 2019 Jul; 32(8):1106-1122. PubMed ID: 30923345
[TBL] [Abstract][Full Text] [Related]
19. [Pulmonary carcinoid: analysis of a single institutional experience and prognostic factors].
Correia Sda S; Pinto C; Bernardo J
Acta Med Port; 2014; 27(6):749-54. PubMed ID: 25641291
[TBL] [Abstract][Full Text] [Related]
20. Interobserver agreement of proliferation index (Ki-67) outperforms mitotic count in pulmonary carcinoids.
Warth A; Fink L; Fisseler-Eckhoff A; Jonigk D; Keller M; Ott G; Rieker RJ; Sinn P; Söder S; Soltermann A; Willenbrock K; Weichert W;
Virchows Arch; 2013 May; 462(5):507-13. PubMed ID: 23559305
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]